Literature DB >> 25899333

Synthesis, crystal structure and effect of indeno[1,2-b]indole derivatives on prostate cancer in vitro. Potential effect against MMP-9.

Gricela Lobo1, Melina Monasterios1, Juan Rodrigues1, Neira Gamboa1, Mario V Capparelli2, Javier Martínez-Cuevas3, Michael Lein4, Klaus Jung4, Claudia Abramjuk5, Jaime Charris6.   

Abstract

A highly regiospecific synthesis of a series of indenoindoles is reported, together with X-ray studies and their activity against human prostate cancer cells PC-3 and LNCaP in vitro. The most effective compound 7,7-dimethyl-5-[(3,4-dichlorophenyl)]-(4bRS,9bRS)-dihydroxy-4b,5,6,7,8,9bhexahydro-indeno[1,2-b]indole-9,10-dione 7q reduced the viability in both cell lines in a time and dose-dependent manner. Inhibitory effects were also observed on the adhesion, migration, and invasion of the prostate cancer cells as well as on clonogenic possibly by inhibition of MMP-9 activity. Molecular docking of 7q and 6k into MMP-9 human active site was also performed to determine the probable binding mode.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; Crystal; Indeno; MMP-9; Prostate; Regiospecif

Mesh:

Substances:

Year:  2015        PMID: 25899333     DOI: 10.1016/j.ejmech.2015.04.023

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Assessment of a bifendate derivative bearing a 6,7-dihydro-dibenzo[c,e]azepine scaffold as a potential anti-metastatic agent.

Authors:  Jingying Qiu; Wang Chen; Yanfei Jiang; Jing Chen; Yinpeng Zhang; Xiaoke Gu
Journal:  Medchemcomm       Date:  2018-09-17       Impact factor: 3.597

Review 2.  Recent applications of ninhydrin in multicomponent reactions.

Authors:  Suven Das
Journal:  RSC Adv       Date:  2020-05-18       Impact factor: 4.036

3.  ATIQCTPC targeting MMP-9: a key step to slowing primary tumor growth and inhibiting metastasis of lewis lung carcinoma in vivo.

Authors:  Yuji Wang; Xinyi Xu; Ce Song; Jianhui Wu; Xi Hu; Haimei Zhu; Xiaoyi Zhang; Yaonan Wang; Lin Gui; Ming Zhao; Shiqi Peng
Journal:  Oncotarget       Date:  2017-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.